At what transferrin saturation level is a patient considered at risk for iron overload?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transferrin Saturation Threshold for Iron Overload Risk

A transferrin saturation ≥50% in men or ≥45% in women indicates risk for iron overload and mandates immediate HFE genetic testing for hereditary hemochromatosis. 1, 2

Evidence-Based Thresholds

The most authoritative guidelines establish clear sex-specific cutoffs:

  • Men: Transferrin saturation >50% combined with ferritin >300 µg/L indicates biochemical iron overload 2
  • Women: Transferrin saturation >45% combined with ferritin >200 µg/L indicates biochemical iron overload 2

The 45% threshold provides 84% sensitivity in men and 73% sensitivity in women for detecting C282Y homozygosity, making it the optimal screening cutoff despite some biological variability 2, 3

Why Transferrin Saturation Matters More Than Ferritin

Transferrin saturation is the primary screening test because it detects iron overload earlier than ferritin 1. Normal transferrin is not more than 50% saturated with iron; when saturation exceeds this physiologic limit, free iron becomes available and tissue deposition begins 1.

Ferritin alone cannot diagnose iron overload because it rises as an acute-phase reactant in inflammation, liver disease, malignancy, and tissue necrosis independent of actual iron stores 1, 2. In contrast, transferrin saturation ≥45% specifically indicates true iron overload requiring genetic evaluation 2.

Clinical Algorithm When Transferrin Saturation is Elevated

Step 1: Confirm the Pattern

  • If TS ≥45% (women) or ≥50% (men): Suspect primary iron overload 2
  • Measure ferritin simultaneously—the combination provides optimal diagnostic accuracy 1, 2
  • **If TS <45% with elevated ferritin:** Iron overload is excluded with >90% certainty; evaluate secondary causes (alcohol, inflammation, NAFLD, malignancy) 1, 2

Step 2: Order HFE Genetic Testing

Immediately test for C282Y and H63D mutations when TS meets threshold 1, 2, 4. C282Y homozygosity confirms HFE-related hereditary hemochromatosis in 85-90% of clinically affected patients 4, 5.

Step 3: Assess for Organ Damage

Check these markers to stratify cirrhosis risk:

  • Liver enzymes (ALT, AST) 1, 2, 5
  • Platelet count 1, 2, 5
  • The combination of ferritin >1,000 µg/L, elevated transaminases, and platelet count <200,000/µL predicts cirrhosis in 80% of C282Y homozygotes 1, 2, 4, 5

Liver biopsy is indicated when: ferritin >1,000 µg/L with elevated liver enzymes, hepatomegaly, age >40 years, or platelet count <200,000/µL 1, 2, 4, 5

Upper Safety Limit: When Does Overload Become Dangerous?

Transferrin saturation >80% is associated with transfusional hemosiderosis and documented organ damage 1. Patients with thalassemia who developed severe iron overload had TSAT levels >88% with ferritin >7,500 ng/mL and experienced liver cell damage 1.

There is no known risk associated with TSAT ≤50% 1. The guidelines explicitly state there is no physiologic rationale for maintaining TSAT >50%, but values between 20-50% are considered safe during iron therapy 1, 6.

Critical Pitfalls to Avoid

Never diagnose iron overload based on ferritin alone without confirming TS ≥45% 1, 2. Over 90% of elevated ferritin cases are caused by inflammation, chronic alcohol consumption, cell necrosis, tumors, or metabolic syndrome—not iron overload 1, 2.

Do not order HFE genetic testing when TS <45%, as this leads to false-positive diagnoses and unnecessary phlebotomy 2, 4. The threshold was specifically chosen to balance sensitivity and specificity 2.

Recognize that up to 33% of C282Y homozygotes may have a normal TS on a single measurement due to biological variability 3. If clinical suspicion is high (family history, suggestive symptoms), repeat testing is warranted 4, 3.

Special Context: Chronic Kidney Disease Exception

In CKD patients on erythropoiesis-stimulating agents, functional iron deficiency can occur despite elevated ferritin when TS <20% 1, 7. This represents iron sequestration by inflammation (hepcidin-mediated), not true overload 2, 7. These patients may benefit from IV iron therapy even with ferritin 100-700 ng/mL if TS remains <20% 1, 2, 7.

Bottom Line for Clinical Practice

Transferrin saturation ≥45% (women) or ≥50% (men) is the evidence-based threshold that signals iron overload risk and triggers the diagnostic cascade for hereditary hemochromatosis. 2 Values below these cutoffs exclude primary iron overload with >90% certainty when ferritin is also within normal limits 2. The upper safety limit is approximately 50%, with documented organ damage occurring at levels >80% 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperferritinemia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Genetic Testing for Elevated Iron Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach for Transferrin Saturation of 70%

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 2001

Research

Assessing iron status: beyond serum ferritin and transferrin saturation.

Clinical journal of the American Society of Nephrology : CJASN, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.